chevron_leftBack
M
As of 24 April 2025, Moss Genomics Inc. has a market cap of $7.43M USD, ranking #34260 globally and #1423 in Canada. It ranks #3432 in the Healthcare sector, and #173 in the Health Information Services industry.
Key Stats
Market Cap
$7.43MUSD
10.29M CAD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Health Information Services
CEO
Jack Liu
open_in_new
Founded
2018
Website
mossgenomics.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 2.2% | 15% | 4.5% | 2K% | 667% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MOSS
Moss Genomics Inc
ISIN: CA61965T1012
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.2300 CAD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Moss Genomics Inc.
Moss Genomics Inc. manufactures and sells personalized health, anti-aging, and wellness products in Canada. The company was formerly known as Nou Camp Capital Corp. and changed its name to Moss Genomics Inc. in July 2021. Moss Genomics Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.
